Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathan Cooper-Knock

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|October 29, 2020
Transcriptomic Analysis of Age-Associated Periventricular Lesions Reveals Dysregulation of the Immune ResponseMotaz M Fadul, Paul R Heath, Johnathan Cooper-Knock, et al.
Iscience|April 13, 2026
hnRNPUL1 has a dead polynucleotide kinase domain that regulates RNA and protein interactionsCarmen V Apostol, Ang Li, Peter Daniels, et al.
Cell Reports Methods|September 18, 2025
SpliPath enhances disease gene discovery in case-control analyses of rare splice-altering genetic variantsYan Wang, Charlotte van Dijk, Ilia Timpanaro, et al.
Frontiers in Molecular Neuroscience|November 25, 2017
Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical PhenotypeJohnathan Cooper-Knock, Henry Robins, Isabell Niedermoser, et al.
Brain : a Journal of Neurology|May 29, 2014
Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansionsJohnathan Cooper-Knock, Matthew J Walsh, Adrian Higginbottom, et al.
Neurology|July 26, 2013
C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic studyJohnathan Cooper-Knock, Antonina Frolov, J Robin Highley, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 7, 2020
Simultaneous ALS and SCA2 associated with an intermediate-length <i>ATXN2</i> CAG-repeat expansionHelia Ghahremani Nezhad, John P Franklin, James J P Alix, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2025
Predicting Phenoconversion to Clinically Manifest ALS: Results of a Large-Scale Proteomic StudyXiming Ran, Joanne Wuu, Zhaohui S Qin, et al.
Brain : a Journal of Neurology|June 27, 2025
Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosisDavid O'Brien, Elham Alhathli, Ceryl Harwood, et al.
Neuropathology and Applied Neurobiology|April 23, 2014
Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neuronesJ Robin Highley, Janine Kirby, Joeri A Jansweijer, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|October 29, 2020
Transcriptomic Analysis of Age-Associated Periventricular Lesions Reveals Dysregulation of the Immune ResponseMotaz M Fadul, Paul R Heath, Johnathan Cooper-Knock, et al.
Iscience|April 13, 2026
hnRNPUL1 has a dead polynucleotide kinase domain that regulates RNA and protein interactionsCarmen V Apostol, Ang Li, Peter Daniels, et al.
Cell Reports Methods|September 18, 2025
SpliPath enhances disease gene discovery in case-control analyses of rare splice-altering genetic variantsYan Wang, Charlotte van Dijk, Ilia Timpanaro, et al.
Frontiers in Molecular Neuroscience|November 25, 2017
Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical PhenotypeJohnathan Cooper-Knock, Henry Robins, Isabell Niedermoser, et al.
Brain : a Journal of Neurology|May 29, 2014
Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansionsJohnathan Cooper-Knock, Matthew J Walsh, Adrian Higginbottom, et al.
Neurology|July 26, 2013
C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic studyJohnathan Cooper-Knock, Antonina Frolov, J Robin Highley, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 7, 2020
Simultaneous ALS and SCA2 associated with an intermediate-length <i>ATXN2</i> CAG-repeat expansionHelia Ghahremani Nezhad, John P Franklin, James J P Alix, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2025
Predicting Phenoconversion to Clinically Manifest ALS: Results of a Large-Scale Proteomic StudyXiming Ran, Joanne Wuu, Zhaohui S Qin, et al.
Brain : a Journal of Neurology|June 27, 2025
Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosisDavid O'Brien, Elham Alhathli, Ceryl Harwood, et al.
Neuropathology and Applied Neurobiology|April 23, 2014
Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neuronesJ Robin Highley, Janine Kirby, Joeri A Jansweijer, et al.
Pageof 11